Almawed Reem, Shiu Jennifer, Bungard Tammy, Charrois Theresa, Gill Pawandeep
, PharmD, ACPR, is with Pharmacy Services, Alberta Health Services, Edmonton, Alberta.
, BScPharm, PharmD, ACPR, is with Pharmacy Services, Alberta Health Services, Edmonton, Alberta.
Can J Hosp Pharm. 2023 Sep 1;76(4):275-281. doi: 10.4212/cjhp.3346. eCollection 2023 Fall.
Pharmacists in the province of Alberta may apply for additional prescribing authorization (APA), which allows them to independently prescribe medications. Currently, no literature exists about pharmacist prescribing for inpatients at the time of discharge.
The primary objective was to report the proportion of patients for whom inpatient pharmacists with APA prescribed at discharge across Alberta, Canada. Secondary objectives were to describe discharge interventions other than prescribing that were provided, enablers of and barriers to discharge prescribing, and differences in discharge prescribing by facility or population type, clinical area, and health care charting system.
A descriptive, cross-sectional web-based survey of inpatient pharmacists with APA across Alberta was conducted over a 6-week period in early 2022.
A total of 104 respondents met the inclusion criteria. Under half (45/102, 44.1%) of the participants reported prescribing at discharge. Those that reported prescribing at discharge did so for only a median 14.5% of their patients. The most common enabler of discharge prescribing was a supportive care team, and the most common barrier was the presence of other prescribers. Pharmacists who did not report prescribing at discharge selected "discomfort with being responsible for the prescription" and "fear of professional liability" as barriers more often than those who did report discharge prescribing (51.0% [26/51] vs 33.3% [13/39] and 43.1% [22/51] vs 25.6% [10/39], respectively). The proportion of pharmacists who reported prescribing at discharge was greater with increasing population/facility size (30% [6/20] of pharmacists in settings that served small populations vs 50% [29/58] of those in settings that served large populations).
Inpatient pharmacists who use APA at discharge reported prescribing for only a minority of patients, and discharge prescribing practices varied widely across the province. Future areas of research include how pharmacists can overcome barriers to prescribing at discharge.
艾伯塔省的药剂师可以申请额外的处方授权(APA),这使他们能够独立开处方。目前,尚无关于药剂师在患者出院时为住院患者开处方的文献。
主要目的是报告在加拿大艾伯塔省,拥有APA的住院药剂师在出院时为患者开处方的比例。次要目的是描述除开处方外提供的出院干预措施、出院开处方的促成因素和障碍,以及不同机构或人群类型、临床领域和医疗保健记录系统在出院开处方方面的差异。
2022年初的6周内,对艾伯塔省拥有APA的住院药剂师进行了一项基于网络的描述性横断面调查。
共有104名受访者符合纳入标准。不到一半(45/102,44.1%)的参与者报告在出院时开处方。那些报告在出院时开处方的人,所开处方的患者仅占其患者中位数的14.5%。出院开处方最常见的促成因素是支持性的护理团队,最常见的障碍是有其他开处方者。未报告在出院时开处方的药剂师选择“对负责处方感到不适”和“担心职业责任”作为障碍的频率高于报告在出院时开处方的药剂师(分别为51.0%[26/51]对33.3%[13/39]和43.1%[22/51]对25.6%[10/39])。随着人群/机构规模的增加,报告在出院时开处方的药剂师比例更高(服务小人群的机构中30%[6/20]的药剂师,而服务大人群的机构中50%[29/58]的药剂师)。
在出院时使用APA的住院药剂师报告只为少数患者开处方,并且全省出院开处方的做法差异很大。未来的研究领域包括药剂师如何克服出院时开处方的障碍。